Abstract
Myanmar pharma generic market is going through rapid changes. It has been through a lot of turmoil– from a conservative approach of government in this field to a free medication for all approach. This study is a journey right from army-ruled country to a democratic country where the market dynamics has rapidly changed in the last 3–4 years Due to this, the market is going through the price correction phase. Cost of products is comparatively high due to the high distribution costs involved. The market will definitely bounce back in the next 3–5 years. Taking this into consideration, “N” number of companies are pouring in, right from big multinational corporations to smaller unheard players from Asian countries.
Get full access to this article
View all access options for this article.